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Background and aims: Multiple rodent models implicate resident intestinal bacteria in the pathogenesis of
chronic immune mediated intestinal inflammation. Specific pathogen free (SPF) interleukin 10 gene
deficient (IL-102/2) mice develop colitis, which does not occur in the germ free (GF) state. We investigated
whether broad or narrow spectrum antibiotics affect onset and progression of disease in various regions of
IL-102/2 mice.
Methods: Metronidazole, ciprofloxacin, vancomycin-imipenem (50 mg/kg/day), or water (control) was
administered orally before (prevention) or two weeks after (treatment) colonisation of GF IL-102/2 mice
with SPF bacteria. After four weeks, colonic histology scores and cytokine production by colonic explants
were determined. Caecal and colonic contents were collected for quantitative bacterial analysis.
Results: In the prevention study, all antibiotics decreased inflammation in the caecum and colon. However,
in the treatment study, ciprofloxacin and vancomycin-imipenem decreased caecal inflammation, and
reduced Escherichia coli and Enterococcus faecalis concentrations, whereas only vancomycin-imipenem
lowered direct microscopic bacterial counts. In contrast, metronidazole and vancomycin-imipenem
reduced colonic injury and eliminated anaerobic bacteria, including Bacteroides spp.
Conclusions: Both narrow and broad spectrum antibiotics can prevent disease but treatment of established
colitis is more selective. Ciprofloxacin is most effective in the treatment of caecal inflammation,
metronidazole preferentially treats the colon, whereas vancomycin-imipenem definitively treats both
regions. These results suggest that subsets of aerobic or anaerobic bacteria show regional differences in
their capacity to mediate experimental colitis in IL-102/2 mice.
I
n recent years, multiple studies have emphasised the role
of commensal intestinal bacteria in the pathogenesis of
inflammatory bowel diseases (IBD).1 2 In several geneti-
cally engineered and induced rodent models of chronic
immune mediated intestinal inflammation, susceptible hosts
develop spontaneous colitis in the presence of non-patho-
genic resident intestinal bacteria, which does not occur in the
germ free (GF) state.3
In a well characterised murine model of T helper 1 (TH1)
mediated colitis, interleukin 10 gene deficient (IL-102/2)
mice develop predominantly caecal inflammation shortly
after weaning when susceptible strains (129 SvEv or mixed
129/C57Bl/6 background) are colonised with specific patho-
gen free (SPF) bacteria.4 5. As disease progresses, inflamma-
tion also develops in the ascending and transverse colon, and
finally in the remainder of the colon and rectum.4 5. In
contrast, GF conditions prevent development of inflamma-
tion in this model, emphasising the essential role of
commensal intestinal organisms in the pathogenesis of
chronic intestinal inflammation.5 These observations are
consistent with results in other models of chronic intestinal
inflammation, such as in HLA-B27/b2 microglobulin trans-
genic (TG) rats, IL-22/2, TCRa2/2, SAMP-1/Yit, and CD3e26
TG mice in which the GF state prevents disease development
and immune activation.6–12 The role of intestinal bacteria in
the pathogenesis of experimental colitis was further empha-
sised after showing that broad spectrum antibiotics can both
prevent and treat colitis in HLA-B27 TG rats and dextran
sulphate sodium (DSS) induced colitis in BALB/c mice,13 as
well as in IL-102/2 mice.14
However, it is relatively unknown how different subsets of
aerobic or anaerobic bacteria influence the onset and
perpetuation of experimental colitis. We describe a study in
gnotobiotic IL-102/2 mice which were colonised with SPF
bacteria that had the following objectives: (1) investigate
whether narrow spectrum antibiotics affect onset and
progression of colitis, (2) explore regional differences in the
prevention and treatment of colonic and caecal inflammation
by antibiotic administration and (3) correlate the therapeutic
effects of narrow spectrum antibiotic treatment with the
composition of intestinal aerobic and anaerobic bacteria.
MATERIALS AND METHODS
Mice
GF IL-102/2 mice (C57BL/66129/Ola mixed background)
were originally derived at the University of Wisconsin
(Gnotobiotic Laboratory, Madison, Wisconsin, USA) and
bred at the gnotobiotic Rodent Care Facility of the Center
for Gastrointestinal Biology and Disease at the College of
Veterinary Medicine (North Carolina State University,
Raleigh, North Carolina, USA).
Experimental design
Two to five months old IL-102/2 mice raised under GF
conditions were transferred to SPF conditions where bedding
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: CFU, colony forming units; FISH, fluorescent in situ
hybridisation; GF, germ free; IBD, inflammatory bowel diseases; IL,
interleukin; IL-102/2, interleukin 10 gene deficient; MLN, mesenteric
lymph node; SPF, specific pathogen free; TG, transgenic; TH1, T helper




from Helicobacter species free SPF mice was added to each
cage. The mice were colonised with Helicobacter species free
SPF bacteria by oral and rectal swabbing with a slurry of
freshly passed faeces, as described previously.5 15
In the prevention study, metronidazole, ciprofloxacin, or a
combination of vancomycin and imipenem was administered
in the drinking water at 50 mg/kg body weight/day starting
at the time of SPF bacterial colonisation; control mice
received only water. Each group consisted of 4–5 mice.
After four weeks, mice were killed and the caecum and
various parts of the colon were collected for histology and
colonic explants cultures.
In the treatment study, gnotobiotic IL-102/2 mice did not
receive any treatment for two weeks after colonisation with
SPF faecal bacteria. Subsequently, metronidazole, ciproflox-
acin, or vancomycin-imipenem was administered in the
drinking water at 50 mg/kg body weight/day; control mice
received only water. Each treatment group consisted of 4–5
mice. At four weeks after the start of antibiotic treatment,
mice were killed and the caecum and colon were collected for
histology and colonic explants cultures. Caecal and colonic
contents were obtained for quantitative bacteriology and
fluorescent in situ hybridisation (FISH), as described below.
All studies were approved by the University of North Carolina
at Chapel Hill Institutional Animal Care and Use Committee.
Histology
At necropsy, transverse and longitudinal sections of the
caecum and proximal, transverse, and distal parts of the
colon were obtained and prepared as previously described.5 15
Briefly, tissues were fixed in 10% formalin, embedded in
paraffin, and stained with haematoxylin and eosin. A
validated histological inflammatory score ranging from 0 to
4 was used for blinded evaluation, based on the degree of
cellular infiltration, crypt hyperplasia, goblet cell depletion,
and architectural distortion.5 15
Colonic tissue fragment cultures
Cultures of colonic fragments were prepared following
published methods,16 as described previously.5 15 Caecal
fragments were not studied because the amounts of available
caecal tissue were too small. Briefly, colonic tissue was
fragmented and the precise weight per well was determined,
which was always in the 50–100 mg range. Colonic tissue
was cultured at 37 C̊ in 1 ml of complete RPMI medium, as
described previously,5 and supernatants were collected after
18 hours and stored at 220 C̊ until assay. IL-1b and IL-12
production were measured and the results were normalised
for the exact tissue weight used per well. Under these
conditions autolysis of colonic fragments, especially epithelial
cells, is expected. However, autolysis is expected to be
consistent in all treatment groups, and therefore should not
affect the outcome.
Cytokine measurements
We used commercially available antimouse IL-1b and IL-12
reagents (BD Pharmingen, San Diego, California, USA) in
validated ELISA protocols to measure amounts of IL-1b and
IL-12 in the colonic culture supernatants.5 15 Cytokine levels
were measured in duplicate and compared with standard
curves using recombinant murine cytokines.
Quantitative bacteriology of caecal and colonic
luminal content
Caecal and colonic contents were collected and serially
diluted at 10-fold dilutions in 16 PBS. For aerobic culture,
the diluted contents were plated and cultured at 37 C̊ for
24 hours on sheep blood agar (total aerobes), Mac Conkey
(Escherichia coli), and bile esculin with azide (enterococci)
agar plates. For anaerobic cultures, caecal and colonic
contents were plated within one hour on BHI (total
anaerobes) or Bacteroides bile esculin agar plates in anaerobic
Gas Pak jars (BBL, Cockeysville, Maryland, USA) at 37 C̊ for
48 hours. Bacterial colonies were counted, identification of
specific organisms was performed by Gram staining, bio-
chemical characterisation using standard biochemical tests,
and confirmed by FISH, as described below. Direct micro-
scopic bacterial counts of caecal and colonic content were
assessed using a Petroffhauser counting chamber prior to
bacterial culture, therefore providing an independent method
of determining bacterial concentrations to complement the
bacterial culture results.
Fluorescent in situ hybridisation
An accurately weighed portion of approximately 100 mg of
caecal or colonic luminal content was diluted 10 times with
filtered (0.2 mm pore size) phosphate buffered saline (PBS).
The diluted samples were homogenised by vortexing for three
minutes with glass beads. Samples were diluted 1:3 with
fresh 4% (w/v) paraformaldehyde in PBS, fixed overnight at
4 C̊, and then stored at 280 C̊ until required. Total
hybridisable cell numbers were counted by diamidino-2-
phenylindole (DAPI) staining.17 Probe BAC303 was used for
the detection of the Bacteroides/Prevotella genera.18 Probe
EC1531 specific for E coli and other Enterobacteriaceae was
used to detect E coli.19 The probe Lab158 was used to detect
lactobacilli and enterococci.20 Enterococci were discriminated
from lactobacilli using probe Efs, as described previously.20
Dilutions of the fixed samples in PBS were applied to slides
with eight wells of 1 cm61 cm (CBN, Drachten, the
Netherlands).21 The slides were either hybridised with
100 ml hybridisation buffer (20 mM Tris HCl, 0.9 M NaCl,
0.1% sodium dodecyl sulphate, pH 7.2) containing 5 ng/ml of
one of the probes described above or stained with DAPI as
described previously.17 The hybridisation assays were carried
out overnight at 50 C̊ in a dark humid chamber (three hours
for the Bac303 and EC23S probes). After hybridisation, the
slides were washed, air dried, and subsequently mounted
with Vecta Shield (Vector Lab., Burlingame, California, USA).
The fluorescent cells in the samples were counted auto-
matically21 with a Leica DMRXA epifluorescence microscope
(Leica, Wetzlar, Germany). However, when the cell number
was lower than 46108 cells/g wet weight, cells were counted
visually using an Olympus BH2 epifluorescence microscope.
All results are stated as bacterial count/g luminal content,
thus normalised for the weight of luminal contents used
during FISH analysis. Oligonucleotide probes were synthe-
sised and purified by Eurogentec (Seraing, Belgium).
Statistical analysis
All data are expressed as mean (SEM). Data were analysed
using the paired Student’s t test or the non-parametric
Mann-Whitney test. Statistical significance was defined as
p,0.05 compared with mice from the water control group.
The Spearman correlation coefficient was computed to
measure the association between histology scores and
bacterial counts, denoted by r. Positive values indicate a
positive correlation, negative values a negative correlation,
and a value of one indicates perfect correlation of the ranks.
As several comparisons were made, p,0.01 was considered




We first studied the ability of narrow and broad spectrum
antibiotics to prevent onset of colitis in GF IL-102/2 mice
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given antibiotics at the time of colonisation with SPF faecal
bacteria.
Histology scores
Figure 1A shows that vancomycin-imipenem was most
effective in preventing both caecal (0.1 (0.2) v 4.0 (0.2)
water; p,0.01) and colonic inflammation (0.1 (0.2) v 2.9
(0.2) water; p,0.01). Ciprofloxacin and metronidazole
partially prevented caecal (1.2 (0.3) ciprofloxacin and 2.8
(0.4) metronidazole v 4.0 (0.2) water; p,0.05 for both) and
colonic (0.7 (0.2) ciprofloxacin, 1.2 (0.2) metronidazole v 2.9
(0.2) water; p,0.05 for both) inflammation.
Colonic cytokine production
All antibiotics significantly decreased IL-1b production by
colonic explant cultures: ciprofloxacin (2.4 (0.8) ng/g tissue;
p,0.05), metronidazole (4.0 (0.1) ng/g tissue; p,0.05), as
well as vancomycin-imipenem preventive therapy (0.4
(0.1) ng/g tissue; p,0.01) compared with the water control
group (19.6 (4.6) ng/g tissue) (fig 1B). Colonic IL-12
production followed the same trend as IL-1b and was
significantly decreased by ciprofloxacin (3.5 (0.8) ng/g tissue;
p,0.05), metronidazole (5.8 (0.9) ng/g tissue; p,0.05), and
vancomycin-imipenem treatment (1.0 (0.2) ng/g tissue;
p,0.01) compared with the water control group (14.7
(3.2) ng/g tissue) (fig 1B).
Treatment study
We then determined whether these antibiotics could reverse
established colitis. We have previously reported that GF
IL-102/2 mice colonised with SPF bacteria develop significant
mucosal inflammation by one week of bacterial colonisa-
tion,15 especially prominent in the caecum (caecal histological
score 2.5 (0.4) in SPF v 0.2 (0.2) in GF IL-102/2 mice
(p,0.001); colonic score 1.9 (0.3)) which progressively
increased to submucosal involvement by three weeks (caecal
histological score 2.9 (0.6); colon 1.8 (0.3)). Thus GF IL-102/2
mice two weeks after colonisation with SPF bacteria have
well established colitis.
Histology scores
Six weeks after SPF colonisation, and four weeks after
antibiotic treatment was started, vancomycin-imipenem was
most effective in reversing both established caecal (0.2 (0.2) v
3.9 (0.2) water; p,0.01) and colonic (0.2 (0.2) v 3.0 (0.3);
p,0.01) inflammation (fig 2A). Ciprofloxacin partially
decreased caecal (1.4 (0.5) v 3.9 (0.2) water; p,0.05) but
not colonic (2.3 (0.3); NS) inflammation whereas metroni-
dazole had no effect on caecal inflammation (3.4 (0.5); NS)
but did partially treat colonic inflammation (1.0 (0.3)
metronidazole v 3.0 (0.3) water control; p,0.05).
Colonic cytokine production
IL-1b production by colonic explants was significantly
decreased by metronidazole (1.5 (0.3) ng/g tissue; p,0.01)
and vancomycin-imipenem (0.8 (0.4) ng/g tissue; p,0.01)
compared with the control group (18.0 (5.3) ng/g tissue)
(fig 2B). However, ciprofloxacin failed to significantly reduce
colonic IL-1b production (12.2 (4.4) ng/g tissue; NS). IL-12
production by colonic explants was decreased by metronida-
zole (6.7 (1.2) ng/g tissue; p,0.05) and vancomycin-imipen-
em (3.3 (0.3) ng/g tissue; p,0.05) compared with water
control mice (21.4 (1.5) ng/g tissue) (fig 2B). Ciprofloxacin





























































Water Ciprofloxacin Metronidazole Vancomycin-
imipenem
Water Ciprofloxacin Metronidazole Vancomycin-
imipenem
Figure 1 Prevention study. (A) Blinded total colonic inflammatory
scores. (B) Spontaneous interleukin (IL)-1b and IL-12 production in
colonic explants cultured for 18 hours. Histological scores (0–4) (A) and
colonic cytokine secretion (ng/g colonic tissue) (B) were evaluated in
gnotobiotic IL-102/2 mice four weeks after specific pathogen free
colonisation, who were simultaneously treated with water, oral
ciprofloxacin, metronidazole, or vancomycin-imipenem (50 mg/kg
body weight/day). Each group consisted of 4–5 mice. Values are mean
























































Water Ciprofloxacin Metronidazole Vancomycin-
imipenem
Water Ciprofloxacin Metronidazole Vancomycin-
imipenem
Figure 2 Treatment study. (A) Blinded total colonic inflammatory
scores. (B) Spontaneous interleukin (IL)-1b and IL-12 production in
colonic explants cultured for 18 hours. Histological scores (0–4) and
colonic cytokine secretion (ng/g colonic tissue) were evaluated in
gnotobiotic IL-102/2 mice six weeks after specific pathogen free (SPF)
colonisation. Two weeks after SPF colonisation resulting in established
colitis, antibiotic treatment (50 mg/kg body weight/day) was started
with water, oral ciprofloxacin, metronidazole, or vancomycin-imipenem.
Each group consisted of 4–5 mice. Values are mean (SEM). *p,0.05,
**p,0.01 versus untreated controls.
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(1.3) ng/g tissue; NS) compared with the water control
group.
Quantitative bacteriology of caecal and colonic
contents
Direct microscopic bacterial counts of caecal contents were
1–2 log lower in the vancomycin-imipenem group compared
with water controls and was unchanged from controls in
ciprofloxacin or metronidazole treated mice (table 1).
Although DAPI stained cell counting only showed a fivefold
reduction in total microbial cells in vancomycin-imipenem
treated mice versus other groups, most of these were
identified as yeasts (table 2). The number of caecal total
aerobic bacteria was significantly lower in ciprofloxacin
treated mice versus other groups. The amounts of E coli and
enterococci species were significantly decreased by ciproflox-
acin and vancomycin-imipenem treatment (table 1).
Metronidazole treatment significantly increased amounts of
luminal E coli. These results were confirmed by FISH of the
same caecal contents, which also identified that enterococci
spp were mainly E faecalis (table 2). Total anaerobic bacterial
amounts were significantly decreased by metronidazole as
well as vancomycin-imipenem treatment, with far greater
effects seen with the combination treatment, as shown in
table 1. FISH detected large populations of lactobacilli in
control mice, which were significantly decreased by cipro-
floxacin and eliminated by vancomycin-imipenem treatment.
Both metronidazole and vancomycin-imipenem decreased
Bacteroides spp amounts below detectable levels, which was
confirmed by FISH (tables 1, 2). No significant differences
were observed between quantitative bacteriological results
from caecal versus colonic bacterial contents (data not
shown).
We then investigated statistical correlations between
histological inflammation and bacterial counts using the
Spearman correlation coefficient as a non-parametric mea-
sure of the correlation of ranks. The correlation of ranks
instead of the correlation of the raw data was computed
because the data were skewed and the assumptions required
to do hypothesis testing on the parametric correlation
coefficient were not satisfied. We merged all treatment
groups to see whether we could show a threshold for either
total microbes or any of the species cultured, related to
perpetuation of colitis. Direct microscopic bacterial counts
strongly correlated with caecal inflammation (r = 0.77,
p = 0.0002) but to a lesser extent with colonic inflammation
(r = 0.53, p = 0.02). Total aerobic counts did not correlate
with overall disease, and in fact were negatively correlated
with colonic inflammation (r = 20.73, p = 0.0006). Caecal
but not colonic inflammation correlated with E coli concen-
trations (r = 0.76, p = 0.0003) and with E faecalis concentra-
tions (r = 0.70, p = 0.001). In contrast, colonic but not caecal
inflammation strongly correlated with total anaerobes
(r = 0.79, p = 0.0001) and Bacteroides spp (r = 0.89,
p = 0.0001).
DISCUSSION
Bacteria and their products play a crucial role in the
pathogenesis of chronic intestinal inflammation in animal
models and human IBD,1 2 providing therapeutic potential for
antibiotics to manipulate the intestinal flora in order to
influence the onset and course of disease. GF IL-102/2 mice
do not have colitis in the absence of intestinal bacteria, but
we showed previously that they rapidly develop a TH1
mediated transmural acute and chronic inflammation within
one week after colonisation with SPF bacteria.15 Therefore,
following identical protocols,15 this model provided us the
opportunity to investigate established colitis two weeks after
SPF colonisation. In our studies, 4–6 weeks after SPF
bacteria, the caecum was consistently more affected than
the colon in IL-102/2 mice.
We first showed that the broad spectrum combination
vancomycin-imipenem almost completely prevented and
treated both caecal and colonic inflammation, in agreement
with previous reports by several authors in various models. A
combination of metronidazole and neomycin prevented and
treated colitis in IL-102/2 mice.14 Vancomycin-imipenem
prevented and treated colitis in HLA-B27 rats, DSS induced
colitis in mice,13 as well as trinitrobenzene sulphonic acid
induced experimental colitis in rats.22 Although the combina-
tion of ciprofloxacin and metronidazole prevented and
treated inflammation in the SAMP1/Yit spontaneous ileitis
model,23 it improved acute but not chronic DSS induced
colitis in mice.24 In human studies the combination of
ciprofloxacin and metronidazole was reported to be effective
in treating refractory pouchitis25 as well as active Crohn’s
disease.26 27
We also showed that narrow spectrum antibiotics such as
ciprofloxacin or metronidazole prevented caecal and colonic
inflammation in gnotobiotic IL-102/2 mice after SPF coloni-
sation, but only selectively reversed established colitis. The
higher efficacy of narrow spectrum antibiotics for prevention
rather than treatment of colitis is in agreement with previous
studies. For example, ciprofloxacin prevented induction of
colitis in IL-102/2 mice born under SPF conditions but
showed only minor effects in established colitis.14
Metronidazole prevented DSS induced colitis in mice but
this antibiotic had no effect after the onset of colitis.24 In
HLA-B27 TG rats and DSS treated mice, oral administration
of either ciprofloxacin or metronidazole prevented colitis but
was less effective in treating established inflammation.13 The
greater efficacy of narrow spectrum antibiotics for preventing
colitis may be explained by the different roles for various
endogenous bacterial species in the different phases of the
inflammatory process. As proposed by Rath et al, some
bacterial species might initiate inflammation while others,
perhaps including a larger spectrum of intestinal bacteria,
perpetuate disease.13 Therefore, it is easier to prevent onset
of colonic inflammation than to treat established disease.
These findings are in agreement with the ability of
recombinant IL-10 to prevent but not treat experimental












Water 38 (12) 5 (2) 7 (3) 48 (20) 86 (30) 32 (8)
MNZ 43 (7) 20 (10) 84 (13)** 57 (30) 4.8 (5)* ,0.001**
Cipro 24 (6) ,0.001** ,0.001** 0.2 (0.1)** 96 (50) 28 (5)
V+I 1 (0.1)** 21 (10) ,0.001** ,0.001** ,0.001** ,0.001**
Direct microscopic bacterial counts and caecal concentrations of aerobic bacteria, Escherichia coli, enterococci, as well as total anaerobic bacteria, including
Bacteroides spp, in gnotobiotic IL-102/2 mice colonised with specific pathogen free flora and treated with ciprofloxacin (Cipro), metronidazole (MNZ), or
vancomycin-imipenem (V+I). Values are given as mean (SEM) colony forming units (CFU) per gram caecal contents.
*p,0.05, **p,0.01 versus water controls.
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chronic granulomatous inflammation induced by bacterial
cell wall polymers in rats.28 This might also explain the
relative lack of efficacy by metronidazole and ciprofloxacin in
the treatment of ileal Crohn’s disease29 whereas metronida-
zole or ornidazole could prevent recurrence of Crohn’s disease
in the neoterminal ileum after ileal resection and primary
ileocolonic anastomosis.30 31
A unique feature of our study is the observation that
narrow spectrum antibiotics showed regional differences in
treating established colitis in IL-102/2 mice. Ciprofloxacin
was most beneficial in the caecum but did not treat colonic
inflammation whereas metronidazole was more effective in
the colon. On the other hand, the broad spectrum antibiotics
vancomycin-imipenem were superior to ciprofloxacin or
metronidazole alone and successfully treated both intestinal
regions. Regional specificity of antibiotics is seen in human
Crohn’s disease in which metronidazole, either alone or in
combination with ciprofloxacin, is more effective in colonic
versus ileal Crohn’s disease,27 29 32 although in a small study
ciprofloxacin did treat Crohn’s ileitis.33 In two other studies,
the efficacy of ciprofloxacin in relation to disease localisation
was not mentioned.34 35 In our study, cytokine production by
colonic explants, normalised for tissue weight, was signifi-
cantly reduced by metronidazole but not by ciprofloxacin,
demonstrating the specificity of ciprofloxacin for the caecal
region rather than the colon.
Treatment with vancomycin-imipenem correlated with a
1–2 log decrease in total luminal bacteria while other
treatments did not significantly decrease total luminal
bacterial concentrations. Similar effects on total caecal
bacterial load by this antibiotic combination have been
reported in HLA-B27 TG rats13 as well as by metronidazole
plus ciprofloxacin treatment in the SAMP/Yit mouse model,23
most likely due to emergence of resistant bacterial species.
Our results confirm the importance of luminal antigenic
bacterial load in the perpetuation of chronic colitis as the
broad spectrum antibiotic combination almost totally elimi-
nated disease. When all treatment groups were merged, there
was a significant correlation between direct microscopic
bacterial counts and histology scores in both the caecum and
colon. However, reduction of bacterial load is not the only
mechanism involved in response to treatment because (1)
narrow spectrum antibiotics have selective therapeutic effects
in different large intestinal regions, despite the lack of effect
on direct microscopic bacterial counts in IL-102/2 mice, (2)
vancomycin-imipenem was more effective than ciprofloxacin
in reducing caecal inflammation, but did not decrease the
total aerobic count, and (3) decreased luminal E coli and
E faecalis concentrations, but not total aerobic counts,
correlated with reduced caecal inflammation. Therefore, our
results suggest that not only reduced bacterial load but also
specific subsets of aerobic bacteria such as E coli, may
preferentially perpetuate caecal inflammation, while anaero-
bic bacteria, including Bacteroides, cause colitis. This hypoth-
esis is consistent with the selective effects of ciprofloxacin in
the caecum and metronidazole in the colon. Ciprofloxacin is
most effective against enteric aerobic Gram negative organ-
isms, and in our study it significantly reduced total caecal
and colonic aerobic bacteria, with undetectable E coli and a
significantly reduced amount of luminal enterococci spp.
Interestingly, in preliminary studies, IL-102/2 mice mono-
associated with E coli preferentially develop caecal
inflammation.36E coli could therefore play a role in the
(induction and) perpetuation of caecal inflammation in SPF
IL-102-/2 mice. Despite elevated amounts of caecal E coli in
HLA-B27 TG rats with severe chronic colitis,37 monoassocia-
tion of these rats with E coli did not induce colitis in these
rats,38 indicating that the ability of E coli to induce and
perpetuate chronic colitis is host dependent. The potential
role of E coli in chronic intestinal inflammation was further
emphasised by the observation that ileal mucosa from
Crohn’s patients with postoperative recurrence contained
more enteroadherent/invasive E coli strains than healthy
controls.39 In addition, IBD patients have increased serum
and mucosal antibody responses to E coli.40 41
Monoassociation of IL-102/2 mice with E faecalis induces a
distal colitis with slow onset of disease, starting at 12 weeks
of colonisation.36 42 43 Although ciprofloxacin reduced caecal
inflammation and luminal concentrations of E faecalis in our
study, the regional localisation (distal colon v caecum) and
the slow onset of disease in monoassociated IL-102/2 mice
make it unlikely that E faecalis plays an important role in
caecal inflammation. Additionally, it also appears unlikely
that E faecalis perpetuates established distal colitis in IL-102/2
mice colonised with SPF bacteria for 4–6 weeks as metroni-
dazole, which selectively decreased colonic inflammation,
had no effect on E faecalis concentrations.
Metronidazole is selectively active against anaerobic
bacteria, including colonic Gram negative Bacteroides spp.44
Metronidazole effectively treated colonic inflammation in our
IL-102/2 mice, significantly reduced luminal anaerobic
bacteria, and eliminated Bacteroides spp, in both the caecum
and colon, suggesting that differences in local luminal
concentrations of these organisms could not explain the
regional variation in colonic inflammation. Thus anaerobic
bacteria appear to have little effect in caecal inflammation in
this model but could play an important role in colonic
inflammation. In selective colonisation studies, a cocktail of
six enteric bacteria, including B vulgatus, induced minimal
colitis in gnotobiotic IL-102/2 mice,5 although monoassocia-
tion with B vulgatus induced colitis in carrageenan fed guinea
pigs and HLA-B27 TG rats.38 45 Additionally, Mann et al
demonstrated that different Bacteroides spp show variability in
pathogenic capacity, with B vulgatus and Bacteroides thetaiota-
micron but not Bacteroides distasonis inducing colitis in
monoassociated HLA B27 TG rats.46 In our study, host
Table 2 Quantitative bacteriology of caecal content by fluorescent in situ hybridisation
Treatment
Total bacterial







Water 86 (21) 6 (2) 40 (38) 114 (39) 141 (40)
MNZ 85 (9) 171 (47)** 78 (40) ,1** 247 (48)
Cipro 31 (7) ,1** ,1** 61 (12) 11 (5)**
V+I 18 (1)** ,1** ,1** ,1** ,1**
Caecal luminal concentrations of Escherichia coli, enterococci, Bacteroides spp, and lactobacilli spp in gnotobiotic
IL-102/2 mice colonised with specific pathogen free flora and treated with ciprofloxacin (Cipro), metronidazole
(MNZ), or vancomycin-imipenem (V+I). Values are given as mean (SEM) per gram of caecal content, measured by
fluorescent in situ hybridisation using probes specific for 16S ribosomal RNA of E coli, Enterococcus faecalis,
Bacteroides spp, and lactobacilli spp.
,1, below detection limit of 107 bacteria/g content.
**p,0.01 versus water controls.
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specificity and pathogenic variability of anaerobic species
might determine which organisms mediate colonic inflam-
mation. Thus it appears likely that metronidazole eliminates
anaerobic intestinal organisms other than B vulgatus, which
could mediate established colitis but not caecal inflammation
in IL-102/2 mice.
Administration of several lactobacillus spp can both
prevent and treat colitis in IL-102/2 mice.47 48 However, our
FISH analysis demonstrated that both vancomycin-imipenem
and ciprofloxacin treatment eliminated lactobacilli spp
whereas metronidazole did not affect endogenous luminal
lactobacilli spp. Therefore, the beneficial effects of antibiotics
are not mediated by increased lactobacilli spp levels.
In conclusion, selective antibiotics and broad spectrum
combination antibiotics can prevent development of inflam-
mation in both the caecum and colon of IL-102/2 mice after
colonisation with SPF bacteria. In contrast, treatment of
established colitis is more selective in its regional therapeutic
response. Ciprofloxacin is most effective in caecal inflamma-
tion and reduces aerobic organisms, including E coli and
E faecalis, whereas metronidazole is preferentially active in
the colon and selectively decreases anaerobic bacteria and
Bacteroides spp. Vancomycin-imipenem treats both regions
very effectively, reduces total luminal bacteria, and elim-
inates specific aerobic and anaerobic organisms. These results
suggest that specific subsets of aerobic and anaerobic
intestinal bacteria selectively perpetuate colitis in the caecum
and colon in this experimental model of chronic intestinal
inflammation.
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Fever, night sweats, and a hepatic mass
Question
A 41 year old Hispanic man with no significant medical
history presented with a two month history of fever, chills,
and night sweats. He denied nausea, vomiting, diarrhoea,
weight loss, cough, and dysuria. On examination he was in
no acute distress, with a temperature of 38.2 C̊ (100.8F), and
normal vital signs. He had mild right upper quadrant
tenderness and an enlarged liver. Initial laboratory data were
remarkable except for microcytic anaemia and an erythrocyte
sedimentation rate of 95. The patient was admitted to the
hospital to investigate his recurring fevers. Although he had
temperatures as high as 40.3 C̊ (104.5F), his infectious
workup was negative. Bacterial cultures of his blood, urine,
and sputum were negative, as were fungal cultures. Serology
for entamoeba, echinococcus, and human immunodeficiency
virus were also negative. In the course of his workup he had a
computed tomography scan of the abdomen. How can this
image explain the clinical scenario?
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Figure 1 Contrast enhanced computed tomography image of the liver.
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